Author: Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program One of the priorities of GO2 for Lung Cancer, alongside many other ally organizations, is to ensure that people diagnosed with lung cancer receive optimal care regardless of their background, [...]
Clinical trials can help anyone—but did you know not all groups have equal representation? A clinical trial is a research study involving people to determine the effectiveness of a new therapy, or combination of therapies. Clinical trials offer people [...]
If there is one thing we learned last year, it is that we are stronger together. Despite the ongoing pandemic in 2021, we rallied our community to help transform survivorship. We persevered and expanded vital services to meet the [...]
By Daniel A. Saez, M.Sc., Treatment and Trials Navigator, GO2 for Lung Cancer Patients often hear the words clinical trial and don’t know what to expect or sometimes even what a clinical trial is. GO2 for Lung Cancer has [...]
When you hear the doctor say the words “small cell lung cancer,” life suddenly changes. You may feel overwhelmed and grieved, lost or angry, or you may feel nothing at all. It is okay to move through all kinds [...]
Hi, I'm Anne Charity Hudley, Ph.D., the North Hall Endowed Chair in the Linguistics of African America and the former Director of Undergraduate Research for the Office of Undergraduate Education at the University of California, Santa Barbara. I study [...]
Stage 4 adenocarcinoma non-small cell (aNSCLC) lung cancer treatment has been dictated in recent years by the genetic mutation, or biomarker. Patients received either chemotherapy, immunotherapy, a combination of the two, or a personalized targeted therapy depending on the [...]
For several years stage 4 adenocarcinoma non-small cell (aNSCLC) lung cancer treatment has been dictated by the genetic mutation, called biomarkers, of the patient. A patient’s treatment was seen as either chemotherapy, immunotherapy (or some sort of combination of [...]
Increasing diversity within lung cancer clinical trials is of critical importance for patients, caregivers, and researchers. To make sure that you are informed and prepared to share the message, we’ve pulled together some helpful blog posts and downloadable materials [...]
Innovative effort aims to improve outcomes for historically underserved lung cancer patient community. SAN CARLOS, Calif. and WASHINGTON, D.C., May 11, 2021 – GO2 for Lung Cancer (GO2 for Lung Cancer) has launched a landmark initiative to identify the [...]